Press coverage about Polarityte (NASDAQ:COOL) has trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Polarityte earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 45.1134757986273 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
COOL stock traded down $0.49 during midday trading on Wednesday, reaching $17.54. 64,988 shares of the company’s stock traded hands, compared to its average volume of 127,567. Polarityte has a twelve month low of $8.00 and a twelve month high of $32.63.
A number of equities analysts have recently weighed in on the company. Cantor Fitzgerald set a $70.00 price objective on Polarityte and gave the company a “buy” rating in a research note on Tuesday, February 20th. ValuEngine raised shares of Polarityte from a “sell” rating to a “hold” rating in a report on Friday, February 2nd.
PolarityTE, Inc, formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves.
Receive News & Ratings for Polarityte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polarityte and related companies with MarketBeat.com's FREE daily email newsletter.